Pharma Industry News

Schumpeter: Britain has second thoughts about foreign takeovers

Written by David Miller

Print section
Print Rubric: 

The world’s most open market for takeovers is having second thoughts

Print Headline: 

The British experiment

Print Fly Title: 

Schumpeter

UK Only Article: 
standard article

Issue: 

France’s next revolution

Fly Title: 

Schumpeter

Main image: 

20170304_WBD000_0.jpg

ONE question prompted by Kraft Heinz’s failed $160bn bid for Unilever is whether Britain still wants to be the world’s entrepot for buying and selling companies. For decades it has been more open to mergers and acquisitions than any other big economy. Britain accounts for 3% of global GDP and its firms make up just 5% of global market capitalisation, but the latter have been involved in a quarter of cross-border M&A activity since 1997, either as buyers or as targets, according to Dealogic, a data firm.
Now Blighty is getting cold feet. The government frowned on the …Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]